// Real-Time Intelligence Feed

Financial Intelligence.
Real-Time.

SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.

14,507
Stories Indexed
Live
Feed Status
6
Data Sources
AllEarningsFDAM&AInsider TradingRegulatoryOfferingLeadershipRestructuringDividendInstitutional HoldingsBankruptcy
FDA · 14,507 results Live
FDA Amneal Nov 27 — 0.00

FDA Approves OXYCODONE AND ACETAMINOPHEN — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced the FDA approval of its generic oxycodone and acetaminophen tablet, a milestone expected to bolster the company's presence in the c…

FDA Allergan, Oct 30 — 0.00

FDA Approves COMBIGAN — Allergan, Inc.

# FDA Approves Allergan's COMBIGAN for Glaucoma Treatment Allergan, Inc. received FDA approval for COMBIGAN (brimonidine tartrate and timolol maleate), an ophthalmic combination t…

FDA Glenmark Oct 9 — 0.00

FDA Approves OXCARBAZEPINE — Glenmark Pharmaceuticals Inc., USA

# FDA Approves Glenmark Pharmaceuticals' Generic Oxcarbazepine Glenmark Pharmaceuticals Inc., USA received FDA approval for its generic oxcarbazepine oral formulation, potentially…

FDA Teva Oct 5 — 0.00

FDA Approves RISEDRONATE SODIUM — Teva Pharmaceuticals USA, Inc.

# FDA Approves Teva Pharmaceuticals' Generic Risedronate Sodium Teva Pharmaceuticals USA, Inc. received FDA approval for its generic formulation of risedronate sodium, a widely-pr…

FDA AUROBINDO Jun 29 — 0.00

FDA Approves Unknown Drug — AUROBINDO PHARMA USA

# FDA Approves Aurobindo Pharma USA Generic Drug Application Aurobindo Pharma USA received FDA approval for ANDA 077873 on June 29, 2007, expanding the company's generic drug port…

FDA PHARM Jun 25 — 0.00

FDA Approves Unknown Drug — PHARM ASSOC

# FDA Approves Generic Drug Application for Pharm Assoc Pharm Assoc has received FDA approval for ANDA078127, expanding its generic drug portfolio and positioning the company to c…

FDA Accord Apr 26 — 0.00

FDA Approves FLUOROURACIL — Accord Healthcare, Inc.

# FDA Approves Accord Healthcare's Generic Fluorouracil Injection Accord Healthcare, Inc. has received FDA approval for its generic intravenous fluorouracil formulation (ANDA04079…

FDA Takeda Feb 23 — 0.00

FDA Approves VYVANSE — Takeda Pharmaceuticals America, Inc.

Takeda Pharmaceuticals America, Inc.'s VYVANSE (lisdexamfetamine dimesylate) received FDA approval for oral administration. The clearance allows the brand to retain its proprietary…

FDA Haleon Feb 7 — 0.00

FDA Approves ALLI — Haleon US Holdings LLC

# FDA Approves Haleon's Orlistat (Alli) for Over-the-Counter Weight Management Haleon US Holdings LLC received FDA approval for Alli (orlistat), marking the first nonprescription …

FDA HERITAGE Feb 6 — 0.00

FDA Approves Unknown Drug — HERITAGE PHARMA AVET

# FDA Approves Heritage Pharma Avet's ANDA Application Heritage Pharma Avet has received FDA approval for its Abbreviated New Drug Application (ANDA077663), expanding the company'…

FDA Strides Jan 31 — 0.00

FDA Approves OXYCODONE HYDROCHLORIDE — Strides Pharma Science Limited

Strides Pharma Science Limited announced the FDA approval of its oral Oxycodone Hydrochloride generic, a move anticipated to intensify competitive pricing and drive generic market …

FDA Dr. Dec 26 — 0.00

FDA Approves ONDANSETRON — Dr. Reddy's Laboratories Limited

# FDA Approves Dr. Reddy's Laboratories' Generic Ondansetron Dr. Reddy's Laboratories Limited received FDA approval for its generic ondansetron hydrochloride oral formulation, exp…

FDA West-Ward Dec 26 — 0.00

FDA Approves ONDANSETRON — West-Ward Pharmaceuticals Corp

West-Ward Pharmaceuticals Corp. secured FDA approval for its intramuscular formulation of ondansetron hydrochloride, a move that positions the company to capitalize on the competit…

FDA STRIDES Nov 6 — 0.00

FDA Approves Unknown Drug — STRIDES PHARMA

Strides Pharma announced the FDA approval of Metolazone Tablets, expanding its portfolio of cardiac and kidney care generic therapies and reinforcing its competitive position in th…

FDA Amneal Oct 24 — 0.00

FDA Approves COLESTIPOL HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

# FDA Approves Amneal Pharmaceuticals' Generic Colestipol Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic colestipol hydrochloride oral …

FDA LANNETT Oct 13 — 0.00

FDA Approves Unknown Drug — LANNETT CO INC

# FDA Approves ANDA for Lannett Co Inc Lannett Co Inc received FDA approval for ANDA077960 on October 13, 2006, expanding its generic drug portfolio and positioning the company to…

FDA Amneal Aug 25 — 0.00

FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals of New York LLC announced the approval of its abbreviated new drug application (ANDA) for hydrocodone bitartrate and acetaminophen, solidifying its presence …

FDA GRAVITI Jul 26 — 0.00

FDA Approves Unknown Drug — GRAVITI PHARMS

Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate revenue through competitive prici…

FDA SOLA Dec 29 — 0.00

FDA Approves CABERGOLINE — SOLA Pharmaceuticals, LLC

# FDA Approves SOLA Pharmaceuticals' Generic Cabergoline The FDA has approved SOLA Pharmaceuticals' abbreviated new drug application for generic cabergoline oral tablets, potentia…

FDA Torrent Dec 7 — 0.00

FDA Approves CARBAMAZEPINE — Torrent Pharmaceuticals Limited

# FDA Approves Torrent Pharmaceuticals' Generic Carbamazepine Torrent Pharmaceuticals Limited has received FDA approval for its generic carbamazepine oral formulation, expanding t…